Date to be confirmed
About the webinar
The Global Burden of Disease (GBD) study is the most comprehensive international epidemiologcal study to date, led by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, Seattle, USA. The study is a key resource in understanding the changing population health issues, facing countries across the world. In the 2019 study, population health trends were examined from 1990 to 2019, including insights on mortality and morbidity in 204 countries and territories, 369 diseases and injuries, and 87 risk factors. By tracking progress within and between countries, it provides an important tool to inform clinicians, researchers, and policy makers, promote accountability, and improve lives worldwide. The forthcoming GBD 2020 will be the first study iteration to incorporate the population health impact of COVID-19.
In this webinar, initial insights on findings from the Global Burden of Disease 2020 study will be presented.
|Welcome & Introduction
— Prof Dr Brecht Devleesschauwer, Action Chair, Sciensano, Belgium
|Initial insights from the Global Burden of Disease 2020 study
— Prof Dr Theo Vos, Institute for Health Metrics and Evaluation, USA
|Questions and answers|